PL2643010T3 - Biologicznie aktywny kompleks i jego otrzymywanie - Google Patents
Biologicznie aktywny kompleks i jego otrzymywanieInfo
- Publication number
- PL2643010T3 PL2643010T3 PL11804746T PL11804746T PL2643010T3 PL 2643010 T3 PL2643010 T3 PL 2643010T3 PL 11804746 T PL11804746 T PL 11804746T PL 11804746 T PL11804746 T PL 11804746T PL 2643010 T3 PL2643010 T3 PL 2643010T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- biologically active
- active complex
- complex
- biologically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1019937.0A GB201019937D0 (en) | 2010-11-24 | 2010-11-24 | Biologically active complex and its preparation |
GBGB1019936.2A GB201019936D0 (en) | 2010-11-24 | 2010-11-24 | Therapeutic method |
EP11804746.3A EP2643010B1 (en) | 2010-11-24 | 2011-11-24 | Biologically active complex and its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2643010T3 true PL2643010T3 (pl) | 2017-05-31 |
Family
ID=45444635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11804746T PL2643010T3 (pl) | 2010-11-24 | 2011-11-24 | Biologicznie aktywny kompleks i jego otrzymywanie |
Country Status (7)
Country | Link |
---|---|
US (2) | US9085643B2 (pl) |
EP (1) | EP2643010B1 (pl) |
DK (1) | DK2643010T3 (pl) |
ES (1) | ES2613986T3 (pl) |
HU (1) | HUE031912T2 (pl) |
PL (1) | PL2643010T3 (pl) |
WO (1) | WO2012069836A2 (pl) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2385954T3 (da) | 2009-01-09 | 2013-06-17 | Hamlet Pharma Ab | Kompleks og fremstillingsproces |
US9085643B2 (en) | 2010-11-24 | 2015-07-21 | Hamlet Pharma Ab | Biologically active complex and its preparation |
JP6092206B2 (ja) * | 2011-07-19 | 2017-03-08 | オヴィジオ イメージング システムズ エン.ヴェー. | 細胞試料内のがん性細胞を検出し、及び/又は分類する方法及びシステム |
WO2014023976A1 (en) * | 2012-08-09 | 2014-02-13 | Hamlet Pharma Ab | Prophylactic and nutraceutical therapy |
GB2536650A (en) | 2015-03-24 | 2016-09-28 | Augmedics Ltd | Method and system for combining video-based and optic-based augmented reality in a near eye display |
CA2997674A1 (en) * | 2015-09-09 | 2017-03-16 | Theoria Science Inc. | Exosome secretion inhibitor |
GB201621752D0 (en) * | 2016-12-20 | 2017-02-01 | Hamlet Pharma Ab | Therapeutically active complexes |
JP6917163B2 (ja) * | 2017-03-07 | 2021-08-11 | 雪印メグミルク株式会社 | 小胞体ストレス軽減用組成物及び該組成物を含む食品、医薬品、飼料 |
JP6917164B2 (ja) * | 2017-03-07 | 2021-08-11 | 雪印メグミルク株式会社 | 小胞体ストレス軽減用組成物及び該組成物を含む食品、医薬品、飼料 |
JP6917165B2 (ja) * | 2017-03-07 | 2021-08-11 | 雪印メグミルク株式会社 | 小胞体ストレス軽減用組成物及び該組成物を含む食品、医薬品、飼料 |
GB201707715D0 (en) * | 2017-05-14 | 2017-06-28 | Hamlet Pharma Ab | Preperation of biologically active complexes |
EP3787543A4 (en) | 2018-05-02 | 2022-01-19 | Augmedics Ltd. | REGISTRATION OF A REFERENCE MARK FOR AN AUGMENTED REALITY SYSTEM |
WO2019243547A1 (en) | 2018-06-20 | 2019-12-26 | Hamlet Pharma Ab | Therapeutically active complexes |
US11766296B2 (en) | 2018-11-26 | 2023-09-26 | Augmedics Ltd. | Tracking system for image-guided surgery |
US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
US12178666B2 (en) | 2019-07-29 | 2024-12-31 | Augmedics Ltd. | Fiducial marker |
US11980506B2 (en) | 2019-07-29 | 2024-05-14 | Augmedics Ltd. | Fiducial marker |
WO2021032807A1 (en) | 2019-08-20 | 2021-02-25 | Hamlet Pharma Ab | Combination of a chemotherapeutic agent and alpha-lactoglubulin-oleic acid complex for cancer therapy |
US11382712B2 (en) | 2019-12-22 | 2022-07-12 | Augmedics Ltd. | Mirroring in image guided surgery |
US11389252B2 (en) | 2020-06-15 | 2022-07-19 | Augmedics Ltd. | Rotating marker for image guided surgery |
US12239385B2 (en) | 2020-09-09 | 2025-03-04 | Augmedics Ltd. | Universal tool adapter |
GB202015836D0 (en) | 2020-10-06 | 2020-11-18 | Hamlet Pharma Ab | Compositions |
US11896445B2 (en) | 2021-07-07 | 2024-02-13 | Augmedics Ltd. | Iliac pin and adapter |
US12150821B2 (en) | 2021-07-29 | 2024-11-26 | Augmedics Ltd. | Rotating marker and adapter for image-guided surgery |
WO2024057210A1 (en) | 2022-09-13 | 2024-03-21 | Augmedics Ltd. | Augmented reality eyewear for image-guided medical intervention |
GB202303177D0 (en) * | 2023-03-03 | 2023-04-19 | Linnane Pharma Ab | Method of predicting response to treatment |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1254199A (en) * | 1997-11-21 | 1999-06-15 | Per Anders Hakansson | Lactalbumin production process |
GB9725126D0 (en) | 1997-11-27 | 1998-01-28 | Svanborg Catharina | Therapeutic agents |
AU5928599A (en) | 1999-09-09 | 2001-04-10 | Efa Sciences Llc. | Methods for treating cell proliferative disorders including cancer |
US6639089B2 (en) | 2000-11-08 | 2003-10-28 | Soda Aromatic Co., Ltd. | Anticancer agents, perfumes or foods and drinks |
GB0205347D0 (en) | 2002-03-07 | 2002-04-24 | Svanborg Catharina | Biologically active complex |
KR100716119B1 (ko) * | 2005-10-24 | 2007-05-10 | (주)케어젠 | 모발 성장을 촉진하는 펩티드 및 이를 이용한 화장품 |
CN101588820A (zh) | 2006-11-17 | 2009-11-25 | 尼亚哈姆雷特药品公司 | α-乳清蛋白组合物 |
WO2008138348A1 (en) | 2007-05-09 | 2008-11-20 | Nya Hamlet Pharma Ab | Preparation of complexed lactalbumin |
DK2385954T3 (da) | 2009-01-09 | 2013-06-17 | Hamlet Pharma Ab | Kompleks og fremstillingsproces |
WO2010131237A1 (en) | 2009-05-13 | 2010-11-18 | Agriculture And Food Development Authority (Teagasc) | A process for producing a biologically active globular protein complex |
US9085643B2 (en) | 2010-11-24 | 2015-07-21 | Hamlet Pharma Ab | Biologically active complex and its preparation |
-
2011
- 2011-11-24 US US13/988,878 patent/US9085643B2/en active Active
- 2011-11-24 HU HUE11804746A patent/HUE031912T2/en unknown
- 2011-11-24 EP EP11804746.3A patent/EP2643010B1/en active Active
- 2011-11-24 DK DK11804746.3T patent/DK2643010T3/en active
- 2011-11-24 ES ES11804746.3T patent/ES2613986T3/es active Active
- 2011-11-24 WO PCT/GB2011/052310 patent/WO2012069836A2/en active Application Filing
- 2011-11-24 PL PL11804746T patent/PL2643010T3/pl unknown
-
2015
- 2015-06-09 US US14/734,913 patent/US9487561B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2643010A2 (en) | 2013-10-02 |
WO2012069836A2 (en) | 2012-05-31 |
US20150344526A1 (en) | 2015-12-03 |
EP2643010B1 (en) | 2016-11-16 |
US20140051636A1 (en) | 2014-02-20 |
HUE031912T2 (en) | 2017-08-28 |
US9085643B2 (en) | 2015-07-21 |
US9487561B2 (en) | 2016-11-08 |
ES2613986T3 (es) | 2017-05-29 |
DK2643010T3 (en) | 2017-02-27 |
WO2012069836A3 (en) | 2012-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2643010T3 (pl) | Biologicznie aktywny kompleks i jego otrzymywanie | |
IL221511A (en) | Arilatriazolones associated with bis aryl and their use | |
HK1206004A1 (en) | Ingenol-3-acylates iii and ingenol-3-carbamates -3- iii -3- | |
GB201012175D0 (en) | Procedure and mechanisms | |
EP2552953A4 (en) | FRIZZLED-BINDING SUBSTANCES AND ITS USES | |
PL2571807T3 (pl) | Sferyczny proszek i jego wytwarzanie | |
HK1184488A1 (en) | Human facilitating cells and uses thereof | |
ZA201208173B (en) | Peptices and their use | |
PL2630159T3 (pl) | Stabilne i rozpuszczalne przeciwciała | |
PL2605757T3 (pl) | Preparaty oparte na nalbufinie i ich zastosowania | |
PL2563131T3 (pl) | Kompozycja szkodnikobójcza i jej zastosowanie | |
EP2608785A4 (en) | LIPOMA CYCLES AND ITS USES | |
ZA201207242B (en) | Pesticidal composition and its use | |
PL2563133T3 (pl) | Kompozycja szkodnikobójcza i jej zastosowanie | |
PT2521445T (pt) | Formulação e utilização da mesma | |
PL2563134T3 (pl) | Kompozycja szkodnikobójcza i jej zastosowanie | |
PT2563806E (pt) | Leucolectinas humanas e suas utilizações | |
GB201006479D0 (en) | Garment and use thereof | |
GB2503802B (en) | Caspofungin analog, and Preparation Method and Uses thereof | |
GB201019937D0 (en) | Biologically active complex and its preparation | |
EP2621490A4 (en) | PROPARGYL-TRIFLUOROMETHOXY-AMINO-BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF | |
HU1000564D0 (en) | Active chair | |
GB201012660D0 (en) | Inhaler and formulation | |
GB201013491D0 (en) | Functionalised biologically active surfaces | |
GB201006380D0 (en) | Excipients and their use |